Theriva Biologics, Inc. (TOVX) announced Loss for full year of -$25.65 million
The company's bottom line totaled -$25.65 million, or -$19.03 per share. This compares with -$18.35 million, or -$28.48 per share, last year.
Theriva Biologics, Inc. earnings at a glance (GAAP) :
-Earnings: -$25.65 Mln. vs. -$18.35 Mln. last year.
-EPS: -$19.03 vs. -$28.48 last year.
For comments and feedback: editorial@rttnews.com